N Verses Capital, LLC Vericel Corp Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
270Shares Held
49MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$403 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$221 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$124 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$104 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.36B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...